SequelSEC

Antiaging Quantum Living Inc. AAQL

Services-Direct Mail Advertising Services · CIK 0001672571 · Fiscal year ends 0331

Revenue
$1.03M
Fiscal year ended 2026-03-31
Operating income
-$835.40K
Fiscal year ended 2026-03-31
Free cash flow
Unavailable
Fiscal year ended 2026-03-31

Antiaging Quantum Living Inc. (AAQL) reported revenue of $1.03M and net income of -$837.65K for the fiscal year ended 2026-03-31. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from Antiaging Quantum Living Inc.’s SEC filings, each linked to the filing it came from.

Income

Antiaging Quantum Living Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-31
Revenue$1.03M$817.90K$7.50K$13.60K$7.40K$3.80K
Cost of revenue$332.26K$389.38K$771Unavailable$1.10K$800
Gross profit$702.12K$428.52K$6.73K$13.60K$6.30K$3.00K
Operating income-$835.40K-$789.96K-$413.02K-$36.63K-$45.01K-$72.94K
Net income-$837.65K-$720.41K-$412.97K-$36.63K-$43.44K-$66.51K
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 31.48Mshares 30.00Mshares 30.00Mshares 30.00MUnavailableUnavailable
Pretax income-$820.99K-$720.41K-$412.97K-$36.63K-$43.44K-$66.51K
Income tax expense$16.66KUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPS$-0.03$-0.02$-0.01UnavailableUnavailableUnavailable
Selling, general & administrative$1.54M$1.22M$419.74KUnavailableUnavailableUnavailable
General & administrative$1.38M$1.06M$348.51K$50.23K$51.31K$75.94K
Selling & marketing$160.73K$158.14K$71.24KUnavailableUnavailableUnavailable

Balance

Antiaging Quantum Living Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-31
Cash & equivalents$503.49K$370.55K$166.55K$354$14.27K$17.50K
Total assets$1.72M$1.59M$1.01M$894$15.12K$68.36K
Current assets$1.21M$810.52K$224.22K$354$14.27K$68.36K
Total liabilities$2.40M$2.72M$1.43M$87.00K$64.60K$74.40K
Current liabilities$1.67M$677.83K$871.45K$87.00K$64.60K$74.40K
Total equity incl. NCI-$675.87K-$1.13M-$413.17K-$86.11K-$49.48K-$6.04K
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$219.04KUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$30.00K$85.79K$2.00KUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailable$901UnavailableUnavailable

Cash flow

Antiaging Quantum Living Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-31
Operating cash flow-$171.02K-$900.28K-$649.41K-$38.22K-$41.14K-$63.98K
Capital expendituresUnavailableUnavailableUnavailableUnavailable$950Unavailable
Investing cash flow-$162.43K-$63.34K-$224.25KUnavailable$49.91K$20.00K
Financing cash flow$460.00K$1.17M$1.04M$24.30K-$12.00KUnavailable
Net change in cashUnavailableUnavailableUnavailable-$13.92K-$3.23K-$43.98K
Stock-based compensationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$134.79K$144.27K$6.99K$314UnavailableUnavailable

Derived

Antiaging Quantum Living Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-31
Free cash flowUnavailableUnavailableUnavailableUnavailable-$42.09KUnavailable
Gross margin67.9%52.4%89.7%100.0%85.1%78.9%
Operating margin-80.8%-96.6%-5507.6%-269.3%-608.2%-1919.4%
FCF marginUnavailableUnavailableUnavailableUnavailable-568.8%Unavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio0.73x1.20x0.26x0.00x0.22x0.92x
Revenue YoY growth26.5%10806.8%-44.9%83.8%94.7%Unavailable
Net margin-81.0%-88.1%-5507.0%-269.3%-587.0%-1750.3%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailable12.8%Unavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open AAQL in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-K · Filed 2026-07-14View SEC filing
10-Q · Filed 2026-02-13View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-K · Filed 2025-07-02View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.